Dr. Arslan A. Kahloon, MD

Dr. Kahloon practices at Erlanger Baroness Hospital in Chattanooga, Tennessee, part of Erlanger Health.

Dr. Kahloon's NPI, 1801025440, was assigned on July 3, 2009. Dr. Kahloon holds Tennessee license 48536.

Dr. Kahloon's primary practice is Erlanger Baroness Hospital, at 975 E 3rd St, Chattanooga, TN 37403 in Hamilton County. The practice phone is (423) 778-7000.

Dr. Kahloon's primary practice is Erlanger Baroness Hospital in Chattanooga, Tennessee, part of Erlanger Health. The medical group on file is Erlanger. Dmand AI also links Dr. Kahloon to 2 more group practices and clinics, 1 community health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kahloon practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Kahloon's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Kahloon's licenses on file in 2 states: Tennessee and Indiana.

CMS data shows 436 Medicare services from Dr. Kahloon across 10 procedure codes in 2024, for 299 Medicare patients. Medicare paid $37,954 for them.

CMS counts 299 Medicare patients who saw Dr. Kahloon in 2024. The largest group is 65 to 74, with 141 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kahloon's median patient age at 59, with 54% women.

In 2024, Dr. Kahloon wrote 558 Medicare Part D claims for 171 patients. 75% of them were for generic drugs. CMS names the drug for 380 of them, across 17 drugs with 11 or more claims each, at $323,020 in total drug cost. In 2023, CMS named 455 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Kahloon for performance year 2024, reported through an alternative payment model (APM). Dr. Kahloon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 132 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Kahloon, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Kahloon, published from 2014 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Cyanoacrylates, Esophageal and Gastric Varices and Gastrointestinal Hemorrhage. Dr. Kahloon has published most often in Cureus. Dr. Kahloon's most frequent co-authors are Rehan A. Kahloon, MD, Naga Prasad Chalasani, MD and Michael V. Chiorean, MD.

Dmand AI links Dr. Kahloon to 2 clinical trials. Conditions studied include Colonic Polyps, Rectal Diseases and Colorectal Neoplasms. Magentiq Eye LTD sponsors the most, 2.

CMS Open Payments shows 389 general payments to Dr. Kahloon from 50 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Abbvie Inc. paid the most, $2,051.